LEVO-ALPHA-ACETYLMETHADOL (LAAM): CLINICAL, RESEARCH, AND POLICY ISSUES OF A NEW PHARMACOTHERAPY FOR OPIOID ADDICTION
Gardado en:
PRENDERGAST, M.L., ET AL., LEVO-ALPHA-ACETYLMETHADOL (LAAM): CLINICAL, RESEARCH, AND POLICY ISSUES OF A NEW PHARMACOTHERAPY FOR OPIOID ADDICTION. JOURNAL OF PSYCHOACTIVE DRUGS, Vol. 27, no. 3 (1995), p. 239-247.
Ref.
46566
Localización:
SIIS R.829
Palabras clave:
Drogodependencias, Fármacos, Investigación, Opiáceos, Tratamiento
Drogodependencias, Fármacos, Investigación, Opiáceos, Tratamiento
Títulos similares: LEVO-ALPHA-ACETYLMETHADOL (LAAM): CLINICAL, RESEARCH, AND POLICY ISSUES OF A NEW PHARMACOTHERAPY FOR OPIOID ADDICTION
- LEVO-ALPHA-ACETYLMETHADOL (LAAM) VERSUS METHADONE: TREATMENT RETENTION AND OPIATE USE
- AN ASSESSMENT OF THE POTENTIAL CROSS-REACTIVITY OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) WITH URINE ASSAYS FOR METHADONE
- THE USE OF LEVO-ALPHA-ACETYLMETHADOL (LAAM) IN METHADONE PATIENTS WHO HAVE NOT ACHIEVED HEROIN ABSTINENCE
- LEVO ALPHA ACETYLMETHADOL (LAAM) VERSUS METHADONE MAINTENANCE: 1 YEAR TREATMENT RETENTION, OUTCOMES AND STATUS
- METHADONE VS. L-ALPHA-ACETYLMETHADOL (LAAM) IN THE TREATMENT OF OPIATE ADDICTION
- LEVO-ALPHA ACETYL METHADOL (LAAM). ITS ADVANTAGES AND DRAWBACKS